Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Gazyvaro
Related studies linked through entity extraction aliases.